On July 26th the Crispr call trade ended in profit. The call options were sold for $0.65 each before fees. Some reasons for the trade are below. The original post on the trade can be found here. On to the next trade!
- Stop price hit.
- Other opportunities showing up
**
This blog is used for informational purposes only. It should not be
used as a recommendation to buy or sell any security. Do your own due
diligence before trading or investing. If you would like up to the
moment communication on KDK Options trades, email at
kdkoptions@gmail.com **
Showing posts with label Crispr Therapeutics. Call Options. Show all posts
Showing posts with label Crispr Therapeutics. Call Options. Show all posts
Tuesday, July 30, 2019
Monday, July 29, 2019
New Call Trade in Crispr Therapeutics
A new call trade has been made with Crispr Therapeutics on July 24th. Two Aug 2nd $55.00 call options were purchased for $0.78 before fees. Stop pricing has been instituted. The expectation is $1.00. Some reasons for the trade are below.
- Earnings coming on 7/29
- Hitting $50.00 resistance
** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **
- Earnings coming on 7/29
- Hitting $50.00 resistance
** This blog is used for informational purposes only. It should not be used as a recommendation to buy or sell any security. Do your own due diligence before trading or investing. If you would like up to the moment communication on KDK Options trades, email at kdkoptions@gmail.com **
Subscribe to:
Posts (Atom)